Friday 7 June 2019

Abdelkader E. Ashour_Organizing Committee Member_Pharmacology Congress 2019


 This universal meet suspects many representatives including worldwide #keynote addresses and #oralpresentations by eminent speakers and notice presentations by understudies, #MedicinalPractices #Exhibitions and #delegates all around the globe which will make a stage for worldwide development of sheltered and viable common treatments. It gives global systems administration and chances to joint efforts with overall organizations and businesses

#CIDRAP_ASP #CAAR_Aus #ECCMID #MicrobeWorld #wileymicrobio #mbiojournal #NatureRevMicro #FEMSTweet #WHO #IDSAInfo #SfAMtweets #WHO

For details visit: https://pharmacology.pharmaceuticalconferences.com/asiapacific/

         

Monday 3 June 2019

Pharmacology Congress 2019_Organizing Committee Member

#PharmacologyCongress2019 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in #Pharmacology & #Toxicology

The prize winning papers will be considered for publication in the international journals once the paper is subjected to standard review procedures


Friday 24 May 2019

PHARMACOLOGY_CONGRESS_2019

🗣YOUNG RESEARCHER FORUM👨‍🔬👩‍🔬

Young Researcher Sessions are organized at the #PharmacologyCongress2019, to provide a unique platform for #YoungResearchers/Investigators for presenting latest #research projects with an in-depth analysis.
share and develop ideas, learn from each other and gain knowledge from senior researchers👥👨‍💼

Monday 1 April 2019

New Research: Cervix Bacteria, Immune factors could be a warning signal of Premature_Birth

                             Pharmacology_Congress_2019



Premature Birth
Knowing which bacteria lurk in the mother's cervix as well as whether she possesses a particular type of immune factor, could hold the key to telling doctors how likely she is to enter premature_labour, and in turn allow them to take preventive measures [University of Maryland].

While sparing or encouraging the protective natural flora of the cervix, the researchers workout an effective method to selectively fight the bacteria that predispose or trigger preterm_birth.

Unconstrained preterm_birth is one of the main cause of death in earliest stages all over the world, including the USA. By definition, this is the point at which the infant is born at less than 37 completed weeks of pregnancy.

Apart from infant_deaths, these complications result in survivors with genuine therapeutic issue, for example, cerebral palsy, loss of vision, and mental disability, which require lifelong care and enormous health related expenditure.
These outcomes could lead the development of precise diagnostic_ tests for women at high risk of preterm_birth. They also recommend new interventional therapeutics for this troublesome condition, for example, immunomodulatory drugs, and probiotics, or other measures to control the microbiome of the cervix and vagina. 

This study involved specialists in obstetrics just as microbiology, and originated from the University of Maryland's School of Medicine, in collaboration with the Perelman School of Medicine at the University of Pennsylvania.
                                        
                      ********************************************************
To know more about recent researches from our eminent speakers, & exhibitions kindly join with us at Pharmacology Congress 2019 | Singapore | September 11-12

The conference's goal will to provide a scientific forum for all international prestige scholars around the world and enable the interactive exchange of research knowledge. The conference will focus on evidence-based benefits proven in clinical trials and scientific experiments. 


     For any generalquery:pharmacology@conferenceint.compharmacology@pharmameetings.net 

Wednesday 27 March 2019

International_Conference | | Recent_research_Updates

                             Pharmacology_Congress 2019
                               
A1c Test
A1c blood_test found to be unreliable in diabetes_diagnoses
Research has discovered that numerous instances of diabetes are missed when the hemoglobin A1c_blood_test is utilized exclusively to analyze the infection.
More than 5 million people in the UK will be living with diabetes by 2025.
Maria Mercedes Chang Villacreses portrays diabetes as a “global epidemic.”
Types of Diabetes:

Type 1 & Type 2
Type 1 diabetes is caused by the immune_system_destroying insulin producing cells in the pancreas.
There are various causes that add to the advancement of type 2 diabetes. A typical risk factor for type 2 diabetes is a family ancestry of the condition. 
Other risk factors incorporate obesity, poor_diet, an inactive way of life, and increased_age.

 https://pharmacology.pharmaceuticalconferences.com/asiapacific/conference-brochure.php


3 Types of blood tests are used to diagnose Diabetes.
Fasting and random_blood_tests are utilized to measure the blood_sugar_levels at a specific point in time.

The A1c_test gives the normal blood glucose levels more than a few months but does not include a period of fasting before the test. There is also an oral glucose resilience test that is completed after an eight-hour fasting period, which is usually used to diagnose gestational_diabetes. 
Lead researcher Maria Mercedes Chang Villacreses, M.D. of city of Hope's Diabetes and Metabolism Research Institute in Duarte, California, has found that the  A1c_test missed the diabetes diagnosis in 73 percent of the 9,000 people included in her study.

Since the incorporation of A1c in 2010, it's been depended on increasingly more for its convenience because patients don't need to quick. However, it is not a perfect test.

The A1c_test is known to deliver varying outcomes in black and Hispanic communities, and iron deficiency and other blood issues can also influence the outcomes produced by the A1c test.

   https://pharmacology.pharmaceuticalconferences.com/asiapacific/abstract-submission.php

Recent_Research: Avocado seeds likely to be rich in Anti-inflammation Properties
Avocado
 Avocado is a well known food item now-a-days. It is rich in minerals and nutrients, along with being a good source of solid fats. Generally people like expending the natural fruit's pulp and reject the huge estimated seed.
However, researchers at the State University of Pennsylvania have said that these discarded avocado seeds possess an extract having essential anti-inflammatory qualities.

As per researchers, the use of avocado seeds along these lines is sensible as they have high amounts of polyphenols. This compound is a natural substance having antioxidant effects. It tends to be useful in protecting cellular level health.

the researchers have revealed that since ancient times, native South Americans have used avocado seeds in treatment of inflammatory  conditions. In fact, the seed has more polyphenol content as compared to the pulp.

                                         *********************************************
                     To know more about recent researches from our eminent speakers, & exhibitions kindly join with us at Pharmacology Congress 2019 | Singapore | September 11-12

The conference's goal will to provide a scientific forum for all international prestige scholars around the world and enable the interactive exchange of research knowledge. The conference will focus on evidence-based benefits proven in clinical trials and scientific experiments. 

For any generalquery:pharmacology@conferenceint.compharmacology@pharmameetings.net                    

Tuesday 26 March 2019

Pharmacology_daily_Updates | Study In Rat | Skin Cancer: Aggressive melanoma | Pharmacology congress 2019 | Singapore


        #Pharmacology Congress 2019

Study In Rat | Mirogabalin may help                                        Lessen_Neuropathic_Pain_Fibromyalgia

Highlights:
       #Rat Model #Mirogabalin besylate #Neuropathic Pain #fibromyalgia

Rat Model

  • A Calcium channel blocker #Mirogabalin besylateapproved as a treatment for Neuropathic Pain in Japan. 
  • Fibromyalgia is a chronic condition consisting of widespread pain. Extreme sensitivity to mechanical stimulus-like pressure.
  • Different manifestations including weariness, rest unsettling influences, and mental issue, for example, despondency and tension are frequently connected to fibromyalgia
  • Researchers trust that pain is not handled accurately at the cerebrum level, prompting extreme affectability and pain perception.  
  • Neuropathic pain is the term used to depict the pain felt by a harmed sensory/nervous system.
  • fibromyalgia can be contemplated in models that emulate pain caused  by harm to the focal or peripheral nervous system.
  • To assess mirogabalin's capability to act as an analgesic for fibromyalgia, scientists utilized two different rat models of fibromyalgia which are: the intermittent cold stress model (ICS) and unilateral intramuscular acidic saline injection model (Sluka model) .

      Know More:   

    
New Research:  Reveals drug compound that could stop the development of an aggressive form of melanoma - Skin Cancer

Highlights: 
        #Pharmacology #Aggressive Melanoma #Skin Cancer #NRAS- Oncogene
        
                                                     
                                                  

  • #Melanoma is a type of skin malignancy that represents 1 percent of all skin cancer cases. Despite this little rate, melanoma is responsible of countless skin cancer death.
  • Over 96,000 people in the United States will develop Melanoma in 2019. More than 7,000 will die as a result ( American Cancer Society ).
  • NRAS - A mutation in a gene causes one form of Melanoma to be particularly aggressive. 
  • NRAS gene encodes a protein of the same name which is primarily involved in regulating cell division. 
  • NRAS: Oncogene: when it mutates, it can transform typical cells into cancerous cells. Melanoma with NRAS mutations represents 20– 30 percent of all melanoma cases.
          https://pharmacology.pharmaceuticalconferences.com/asiapacific/registration.php


       Key Resource: American Cancer Society, Cancer Research Articles




                           For any general Query: pharmacology@pharmameetings.net

Monday 25 March 2019

#Pharmacology Congress 2019 | Latest_Research_Updates

                                              TB reinfection

                    The risk of TB re-infection can easily increase by Anti-TB drugs

Anti-TB Drugs
                                   Treatment leads to changes in gut bacteria

Current treatments for tuberculosis(TB) are very effective in controlling TB infections which is caused by Mycobacterium tuberculosis (Mtb) & however they may not always prevent reinfection. 

What is the reason for which Anti-TB drugs may not prevent reinfections is one of the long-standing question in TB Research

Anti-tuberculosis drugs cause changes to gut microbiota and increase susceptibility to Mycobacterium tuberculosis(Mtb) is a major reason for which current treatments are ineffective in preventing reinfections.  

Why are human bodies unable to generate permanent immunity to TB ?

A team of scientists at the Research Institute of the McGill University Health Centre (RI-MUHC) and McGill University doing research in Mucosal Immunology, they showed that anti-TB drugs caused changes to gut microbiota which is the diverse community of microbes living our intestines  and increased susceptibility to Mtb infection.

                                

Gut microbiota

  • critical to keeping us healthy
  • help to digest food
  • combat pathogenic microbes
  • reinforce our immune system
Recent research has shown that chronic use of antibiotic leads to disruption of this community, which can in turn lead to dysregulation of the immune system. It remains unclear, however, whether changes in the composition of the microbes living in our gut have an influence on TB infection.

Dr. Irah King and Maziar Divangahi from the Meakins-Christie Laboratories at the RI-MUHC, with colleagues from McGill's Macdonald Campus, treated mice with the most commonly used anti-TB drugs - isoniazid, rifampicin and pyrazinamide.

Researchers are already thinking of monitoring patients who are being treated with these drugs to see how their gut microbiota changes over time and once treatment has stopped. The idea will be to control changes to the microbiome in combination with drugs that are effective at killing Mtb.

Key Resource:  McGill University, Journals


                         14th World Congress on Pharmacology and Toxicology


                                                September 11-12, 2019 Singapore

                               Theme: Accelerations and Decelerations in Drug Discovery

                  For any general query drop a mail:pharmacology@conferenceint.com